US packaging group MeadWestVaco (MWV) has launched its Med-Easy pharmaceutical packaging solution in Europe in an effort to appeal to patients who need to take their treatments on the move.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Roche appointing Genentech’s CEO to lead its pharma division and Mylan’s CFO leaving after three months in the job.
Ark Therapeutics is using its expertise and spare capacity to move into the contract manufacturing sector and is hoping to sign deals to produce the DNA-based medicine.
Source BioScience (SBS) is eyeing acquisitions and investments in technology after it posted a profit in the first six months of 2009, overturning a loss in the same period of last year.
Sterile injectables, specialty pharmaceuticals and discovery services will be key drivers for Jubilant Organosys over the 2010 fiscal year, according to executive finance director R Sankaraiah.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at WuXi, Dishman and Sartorius Stedim.
PDI has entered into a strategic alliance with The Medical Affairs Company (TMAC) to offer “a more complete set of field-based commercialisation solutions”.
in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.
Novozymes Biopharma is building a new Bacillus-based hyaluronic acid (bHA) production facility in China to meet “increasing demand” for the substance that has drug delivery applications.
The new chairman of US trade body the Pharmaceutical Research and Manufacturers of America (PhRMA) – AstraZeneca CEO David Brennan – has laid out his vision for reforming the “broken” healthcare system.
US company CardioNet, which specialises in mobile cardiac monitoring devices, has made a foray into the contract research sector with a $14m offer to acquire cardiovascular research firm Biotel.
ReSearch Pharmaceutical Services has expanded its activities into the Asian market via the purchase of Chinese contract research organisation (CRO) Paramax International.
A US pharmacy’s attempt to implement simpler packaging that clearly communicates information to patients has failed to improve compliance, according to a study.
Regulators in the UK and Australia have issued GMP certificates for Ranbaxy Laboratories' Paonta Sahib plant after a joint inspection deemed manufacturing practices were up to code.
Covance has expanded its clinical pharmacology capabilities via the purchase of Swiss Pharma Contract, a 50-bed clinical research company based in Basel.
US contract research organisation ACM Global Central Laboratory has bought its longstanding business partner Pivotal Laboratories of the UK in a bid to boost its international reach.
MD Logistics has added a 15,000 sq ft of cold-storage facility to its distribution operations in Indiana, US in response to the rising demand for biologics transportation services.
Millipore hopes its $23m (€18m) swoop for Guava Technologies will draw attention away from the underperformance of its bioprocess division, revenue from which fell 6 per cent in Q4 to $214m (€165m) and 2 per cent for 2008 overall.
Merck & Co’s thirst for outsourcing continues, with United Parcel Services (UPS) taking over two of its distribution centres and providing services from for the pharma company from the sites.
DHL Global Forwarding has opened a Life Science Competency Center in Carolina, Puerto Rico, which will offer shipping services tailored to the needs of the island’s biotech and pharmaceutical companies.
Recent European legislation designed to increase the number of children in clinical trials has had a positive impact in ensuring that paediatric patients are included in medicine testing.
Merck Serono has begun work on the expansion of its Swiss biotech facility, with the additional capacity being used to meet rising demand for Erbitux (cetuximab).
NeoStem has agreed to acquire China Biopharmaceuticals Holdings in an attempt to capitalise on the manufacturing and marketing opportunities in the nation.
Increasing bureaucracy in clinical research in the UK is posing a threat to the industry, according to a report published in the British Medical Journal.
in-PharmaTechnologist.com's periodic round-up of developments and deals in the pharmaceutical manufacturing space, includes news on 3M and Ligacon, Dishman, Stiefel and Barrier and Forbes.
Cardinal Health’s announcement that it is considering spinning off some of its divisions has provoked fevered speculation among industry analysts and media observers alike.
Pharmaceutical company Enzon may hive off its entire specialty drugs division, including a manufacturing facility in Indianapolis, US, in the face of pressure from shareholder Carl Icahn.
Ireland's Almac Group has announced the creation of a new oncology
division that will focus on the discovery and development of "novel
and innovative" approaches to treatment in this key disease area.
GE Healthcare has announced its intention to invest $20m in radical
new technology, which will allow laboratory research results to be
transmitted and shared amongst doctors worldwide setting to define
a new age in patient care.
Dutch chemical group DSM has acquired Polymer Technology Group
(PTG) and predicted its best financial year to date following
organic sales growth of 14 per cent for the first quarter.
Malaysia's pharmaceutical star is likely to rise as of this year,
with an eventual position being gained amongst some of the world's
industry leaders being predicted by Frost & Sullivan.
Merck & Co has signed a $32m deal to evaluate MicroDose
Technologies' dry powder inhalation technology in the delivery of
some of its respiratory product lines.
Alfacell, Phoqus Pharmaceuticals, Watson Pharmaceuticals, Stem Cell
Sciences, Kythera Biopharmaceuticals and ISPE have all had people
on the move in the world of pharmaceutical manufacturing.
